Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

Immunoadsorption successfully treated a man's resistant polymyositis.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Alopecia areata involves unique activation of certain immune cells.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

The combination therapy was effective and well-tolerated, especially in young patients.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Post-steroid panniculitis is now rare because doctors taper steroids more carefully.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

The Pfizer COVID-19 vaccine may rarely trigger nail psoriasis.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

Some medications caused temporary health issues that improved after stopping the drugs, but two patients died from liver problems linked to carbamazepine.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Long COVID causes lasting symptoms and needs ongoing care.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.